The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksInter. Pers. Regulatory News (IPF)

Share Price Information for Inter. Pers. (IPF)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 104.00
Bid: 103.50
Ask: 105.00
Change: -2.00 (-1.89%)
Spread: 1.50 (1.449%)
Open: 106.00
High: 106.00
Low: 103.50
Prev. Close: 106.00
IPF Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Final Confirmation & Results of Exchange Offer

7 Jun 2019 17:01

RNS Number : 5869B
International Personal Finance Plc
07 June 2019
 

The information contained herein may only be released, published or distributed in the United Kingdom, the Isle of Man, Jersey and the Bailiwick of Guernsey in accordance with applicable regulatory requirements. The information contained herein is not for release, publication or distribution in or into the United States, Australia, Canada, Japan, South Africa, the Republic of Ireland or in any other jurisdiction where it is unlawful to distribute this document.

THIS ANNOUNCEMENT RELATES TO THE DISCLOSURE OF INFORMATION THAT QUALIFIED OR MAY HAVE QUALIFIED AS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE 7(10) OF THE MARKET ABUSE REGULATION (EU) 596/2014.

SEE "IMPORTANT INFORMATION" BELOW

 

 

INTERNATIONAL PERSONAL FINANCE PLC (THE "ISSUER")

 

7 June 2019

 

Final Terms Confirmation and Results of Exchange Offer Announcement

 

This announcement constitutes the Final Terms Confirmation Announcement referred to in (i) the Final Terms dated 16 May 2019 relating to the proposed issue by the Issuer of 7.75 per cent. notes due 2023 for cash (the "Additional Notes Final Terms"); and (ii) the Final Terms contained in pages 58 to 69 of the Exchange Offer Memorandum dated 16 May 2019 (the "Exchange New Notes Final Terms" and the "Exchange Offer Memorandum") relating to the proposed offer for exchange of the Issuer's outstanding sterling denominated 6.125% bonds due 2020 (ISIN: XS0919406800) (the "Existing 2020 Notes") for 7.75 per cent. notes due 2023.

This announcement also hereby announces the results of the Exchange Offer referred to in the Exchange Offer Memorandum. This announcement must be read in conjunction with, and as applicable, the Prospectus, the Supplementary Prospectus, the Exchange Offer Memorandum (including the Exchange New Notes Final Terms) and the Additional Notes Final Terms (in all cases as defined above or below).

The Prospectus, the Supplementary Prospectus, the Exchange Offer Memorandum (including the Exchange New Notes Final Terms) and the Additional Notes Final Terms are available for viewing on the website of Lucid Issuer Services Limited (https://portal.lucid-is.com).

The Exchange Period relating to the Exchange Offer and the Offer Period relating to the offer of Additional Notes expired at 12 Noon on 7 June 2019 and accordingly the Exchange New Notes and the Additional Notes (together, the "Notes") can no longer be subscribed for nor be obtained by way of application for exchange. Accordingly, this announcement is not an offer to subscribe, tender, sell or exchange any securities.

Unless otherwise defined herein, terms used herein shall, as applicable, have the meaning given to them in the base prospectus published on 12 April 2019 (the "Prospectus") as supplemented by a supplementary prospectus published on 7 May 2019 (the "Supplementary Prospectus"), the Exchange Offer Memorandum and the Additional Notes Final Terms.

The Exchange New Notes and the Additional Notes to be issued will be consolidated and form a single series on the Issue Date, with ISIN XS1998163148.

The Issuer confirms the following for the purposes of this Final Terms Confirmation Announcement:

Aggregate Nominal Amount of the Series of Notes to be issued:

£78,100,000

Estimated net proceeds of the offer of the Series of Notes to be issued:

£19,492,300 (being the Aggregate Nominal Amount of the Notes issued pursuant to the Cash Offer at the Issue Price of 100% less the fees payable to the Dealer Managers in respect of both the issuance of the Additional Notes and the Exchange New Notes; and

£57,401,900 in the form of the aggregate nominal amount of Existing 2020 Notes accepted for exchange pursuant to the Exchange Offer.

Estimated expenses relating to the offer of the Series of Notes to be issued:

£1,205,800 (being the fees payable to the Dealer Managers in relation to both the Exchange New Notes and the Additional New Notes and deducted as described in estimated net proceeds of the offer of the Series of Notes to be issued above).

In relation to the Exchange Offer, the aggregate nominal amount of Existing 2020 Notes accepted for exchange by the Issuer is £57,401,900. Accordingly, the aggregate nominal amount of Existing 2020 Notes outstanding after the Exchange Offer will be £44,098,100.

 

-Ends-

 

For further information, please see IPF's website at http://www.ipfin.co.uk or contact:

 

James Ormrod (Chief Legal Officer)

+44 (0) 113 285 6824

Rachel Moran (Investor Relations Manager)

+44 (0) 113 285 6798

Nick Dahlgreen (Group Treasurer)

+44 (0) 113 285 6921

IMPORTANT INFORMATION

This announcement is released by International Personal Finance plc and contains information that qualified or may have qualified as inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 (MAR), encompassing information relating to an offer of securities, as described above. For the purposes of MAR and Article 2 of Commission Implementing Regulation (EU) 2016/1055, this announcement is made by James Ormrod, Chief Legal Officer for International Personal Finance plc.

The offering and the distribution of this announcement and other information in connection with any offer in certain jurisdictions may be restricted by law and persons into whose possession this announcement or any document or other information referred to herein comes should inform themselves about and observe any such restriction. Any failure to comply with these restrictions may constitute a violation of the securities laws of any such jurisdiction.

This announcement does not constitute or form part of any offer or invitation to sell, or any solicitation of any offer to purchase. Any purchase of Notes pursuant to any offer should only be made on the basis of (as applicable) the information contained in the Base Prospectus, the Supplementary Prospectus, the Exchange Offer Memorandum, the Additional Notes Final Terms and the Exchange New Notes Final Terms referred to above. The Base Prospectus, the Supplementary Prospectus, the Exchange Offer Memorandum, the Additional Notes Final Terms and the Exchange New Notes Final Terms are available for viewing at (https://portal.lucid-is.com).

The Notes have not been and will not be registered under the US Securities Act of 1933, as amended, (the "Securities Act") and, subject to certain exceptions, may not be offered, sold or delivered within the United States or to, or for the account or benefit of U.S. persons (as defined in the Securities Act). The Notes are being offered and sold outside of the United States in reliance on Regulation S of the Securities Act. There will be no public offering in the United States.

Legal Entity Identifier: 213800II1O44IRKUZB59

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCLLFEERRIDIIA
Date   Source Headline
22nd Jul 20224:40 pmRNSSecond Price Monitoring Extn
22nd Jul 20224:36 pmRNSPrice Monitoring Extension
1st Jul 202210:13 amRNSBlock listing Interim Review
1st Jul 202210:08 amRNSTotal Voting Rights
20th Jun 20223:57 pmRNSDirectorate Change
16th Jun 20224:43 pmRNSDirector/PDMR Shareholding
1st Jun 20229:10 amRNSTotal Voting Rights
31st May 20223:12 pmRNSDirector/PDMR Shareholding
5th May 20229:55 amRNSTotal Voting Rights
28th Apr 20223:03 pmRNSResult of AGM
28th Apr 20227:00 amRNSQ1 2022 Trading Update
6th Apr 202212:16 pmRNSDirector/PDMR Shareholding
1st Apr 20229:33 amRNSTotal Voting Rights
23rd Mar 20223:37 pmRNSAnnual Financial Report
10th Mar 20221:38 pmRNSDirector/PDMR Shareholding
8th Mar 20224:38 pmRNSHolding(s) in Company
23rd Feb 20227:00 amRNSFinal Results and Accounts
22nd Feb 202211:05 amRNSDesignation of EU Home Member State
11th Feb 20222:16 pmRNSApproval of Warsaw Stock Exchange Delisting
27th Jan 20223:59 pmRNSHolding(s) in Company
4th Jan 20222:19 pmRNSBlock listing Interim Review
1st Dec 202110:00 amRNSTotal Voting Rights
29th Nov 20217:00 amRNSConsolidated Financial Report 30 September 2021
9th Nov 20217:00 amRNSBoard Appointment
3rd Nov 20217:00 amRNSQ3 2021 Trading Update
13th Oct 20219:45 amRNSHolding(s) in Company
5th Oct 20219:27 amRNSPricing of New Notes
27th Sep 20217:51 amRNSPotential issuance of SEK floating rate notes
16th Sep 202112:28 pmRNSResult of General Meeting
26th Aug 20215:08 pmRNSPublication of a Prospectus
24th Aug 20213:51 pmRNSHolding(s) in Company
24th Aug 20213:47 pmRNSHolding(s) in Company
19th Aug 20217:00 amRNSNotice of GM
28th Jul 20219:08 amRNSHolding(s) in Company
27th Jul 20217:00 amRNSQuarterly Financial Report 31 March 2021
27th Jul 20217:00 amRNSHalf-year Report - 30 June 2021
14th Jul 20219:13 amRNSNotice of results
1st Jul 20214:53 pmRNSBlock listing Interim Review
15th Jun 20217:00 amRNSUpgrade to market expectations
4th Jun 202110:33 amRNSDirector/PDMR Shareholding
1st Jun 20211:49 pmRNSTotal Voting Rights
13th May 20214:00 pmRNSDirector/PDMR Shareholding
29th Apr 20211:08 pmRNSResult of AGM
29th Apr 20217:00 amRNSQ1 2021 Trading Update and board change
16th Apr 20214:06 pmRNSDirector/PDMR Shareholding
15th Apr 20215:21 pmRNSHolding(s) in Company
7th Apr 20211:46 pmRNSHolding(s) in Company
30th Mar 20213:56 pmRNSDesignation of EU Home Member State
24th Mar 202110:26 amRNSDirector/PDMR Shareholding
23rd Mar 20214:21 pmRNSAnnual Financial Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.